Thiis is Michael Triplett, PhD, CEO, Myonexus Therapeutics.
Credit
Myonexus Therapeutics
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.